XS-04: A first-in-class dual IRAK4/BTK inhibitor for the treatment of hematological malignancies

Zhao, CY; Wang, JF; Liu, AG; Gao, X; Teng, YF; Liu, L; Zhang, Y; Yu, XH

CANCER RESEARCH, 2023; 83 (7):